Mast Therapeutics plans to price public offering of stock and warrants

Bookrunning manager Cowen helps sell series A and series B units

By Devika Patel

Knoxville, Tenn., Nov. 5 – Mast Therapeutics, Inc. said it plans price a public sale of units.

The company will sell series A units of common stock and warrants or series B units of prefunded warrants, exercisable at $0.01 per share, and warrants.

Cowen and Co., LLC is the bookrunner.

The biopharmaceutical company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.